THE RELATIONSHIP BETWEEN CHOLESTERYL ESTER TRANSFER ACTIVITY AND HIGH-DENSITY LIPOPROTEIN COMPOSITION IN HYPERLIPIDEMIC PATIENTS

被引：0
|
作者：
SPARKS, DL [1 ]
FROHLICH, J [1 ]
PRITCHARD, PH [1 ]
机构：
[1] UNIV BRITISH COLUMBIA,VANCOUVER V6T 1W5,BC,CANADA
来源：
ARTERIOSCLEROSIS | 1988年 / 8卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A581 / A582
页数：2
相关论文
共 50 条
  • [41] Comparison of the effects of diet and simvastatin on serum high-density lipoprotein cholesterol and cholesteryl ester transfer protein activity in outpatients with hypercholesterolemia
    Saito, N
    Kannagi, T
    Sayama, H
    CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 1999, 60 (05): : 266 - 277
  • [42] ALTERATIONS IN LIPOPROTEIN COMPOSITION AND ACCELERATED CHOLESTERYL ESTER TRANSFER IN PATIENTS WITH HYPERCHOLESTEROLEMIA
    RITTER, MC
    SUBBAIAH, PV
    BAGDADE, JD
    CLINICAL RESEARCH, 1989, 37 (04): : A887 - A887
  • [43] THE UPTAKE OF HIGH-DENSITY LIPOPROTEIN CHOLESTERYL ESTER IN THE PERFUSED-RAT-LIVER
    QUARFORDT, S
    HANKS, J
    JONES, RS
    SHELBURNE, F
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1980, 255 (07) : 2934 - 2937
  • [44] Cholesteryl Ester Transfer Protein Inhibition With Anacetrapib Decreases Fractional Clearance Rates of High-Density Lipoprotein Apolipoprotein A-I and Plasma Cholesteryl Ester Transfer Protein
    Reyes-Soffer, Gissette
    Millar, John S.
    Ngai, Colleen
    Jumes, Patricia
    Coromilas, Ellie
    Asztalos, Bela
    Johnson-Levonas, Amy O.
    Wagner, John A.
    Donovan, Daniel S.
    Karmally, Wahida
    Ramakrishnan, Rajasekhar
    Holleran, Stephen
    Thomas, Tiffany
    Dunbar, Richard L.
    deGoma, Emil M.
    Rafeek, Hashmi
    Baer, Amanda L.
    Liu, Yang
    Lassman, Michael E.
    Gutstein, David E.
    Rader, Daniel J.
    Ginsberg, Henry N.
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2016, 36 (05) : 994 - 1002
  • [45] High-density lipoprotein (HDL) elevation by cholesteryl ester transfer protein inhibition promotes insulin secretion in humans
    Kingwell, B. A.
    Siebel, A. S.
    Natoli, A. K.
    Yap, F.
    Carey, A. L.
    Sviridov, D.
    Weber, C. I. Kiu
    Meneses-Lorente, G.
    Maugeais, C.
    Forbes, J. M.
    EUROPEAN HEART JOURNAL, 2012, 33 : 36 - 36
  • [46] The association of cholesteryl ester transfer protein polymorphism with high-density lipoprotein cholesterol and coronary artery disease in Koreans
    Park, KW
    Choi, JH
    Kim, HK
    Oh, S
    Chae, IH
    Kim, HS
    Oh, BH
    Lee, MM
    Park, YB
    Choi, YS
    CLINICAL GENETICS, 2003, 63 (01) : 31 - 38
  • [47] Where are we with high-density lipoprotein raising and inhibition of cholesteryl ester transfer for heart disease risk reduction?
    Schaefer, Ernst J.
    Asztalos, Bela F.
    CURRENT OPINION IN CARDIOLOGY, 2007, 22 (04) : 373 - 378
  • [48] Thyroid hormone increases plasma cholesteryl ester transfer protein activity and plasma high-density lipoprotein removal rate in transgenic mice
    Berti, JA
    Amaral, MEC
    Boschero, AC
    Nunes, VS
    Harada, LM
    Castilho, LN
    Oliveira, HCF
    METABOLISM-CLINICAL AND EXPERIMENTAL, 2001, 50 (05): : 530 - 536
  • [49] Elevation of high-density lipoprotein cholesterol: future perspective. Cholesteryl ester transfer protein as a therapeutic target
    Civeira, F.
    Mateo-Gallego, R.
    Burillo, E.
    Cenarro, A.
    CLINICA E INVESTIGACION EN ARTERIOSCLEROSIS, 2010, 22 : 44 - 48
  • [50] Increasing high-density lipoprotein cholesterol, inhibition of cholesteryl ester transfer protein, and heart disease risk reduction
    Schaefer, Ernst J.
    Asztalos, Bela F.
    AMERICAN JOURNAL OF CARDIOLOGY, 2007, 100 (11): : 25N - 31N
12345